Landmark study finds more breast cancer patients can safely forgo chemotherapy

A 21-gene test performed on tumors could enable most patients with the most common type of early breast cancer to safely forgo chemotherapy, according to a landmark study published in the New England Journal of Medicine.Loyola Medicine oncologist Kathy Albain, M.D., is among the main co-authors of the study.
Go to Source